World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
145
Citations
109797
World Ranking
1357
National Ranking
790

Overview

Daniel E. Furst is affiliated with the University of California, Los Angeles in the United States. Their main field of study is Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Rheumatology, Immunology, and Dermatology. This multidisciplinary expertise informs their research approach across a range of related topics.

The scientist's research primarily addresses areas such as:

  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Mast cells and histamine
  • Dermatologic Treatments and Research
  • Inflammatory Myopathies and Dermatomyositis
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research

Frequent publication venues for Daniel E. Furst include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Journal of Scleroderma and Related Disorders
  • Arthritis & Rheumatology
  • ACR Open Rheumatology

Their recent published papers illustrate contributions primarily in topics related to systemic sclerosis and interstitial lung disease:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease, 2021, Arthritis & Rheumatology
  • Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial, 2021, American Journal of Respiratory and Critical Care Medicine
  • Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis, 2020, Arthritis & Rheumatology
  • Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management, 2020, Annals of the Rheumatic Diseases

Among frequent coauthors with whom Daniel E. Furst has collaborated are:

  • Dinesh Khanna
  • Marco Matucci-Cerinic
  • Christopher P. Denton
  • Oliver Distler
  • Yannick Allanore

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

    R Maini;E W St Clair;F Breedveld;D Furst

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

    David T. Felson;David T. Felson;Jennifer J. Anderson;Jennifer J. Anderson;Maarten Boers;Claire Bombardier;Claire Bombardier

  • Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

    Michael E. Weinblatt;Edward C. Keystone;Daniel E. Furst;Larry W. Moreland

  • 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

    Jasvinder A. Singh;Daniel E. Furst;Aseem Bharat;Jeffrey R. Curtis

  • American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

    Kenneth G. Saag;Gim Gee Teng;Nivedita M. Patkar;Jeremy Anuntiyo

  • Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

    Daniel O. Clegg;Domenic J. Reda;Crystal L. Harris;Marguerite A. Klein

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial

    Larry W. Moreland;Michael H. Schiff;Scott W. Baumgartner;Elizabeth A. Tindall

  • 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Dinesh Khanna;John D. FitzGerald;Puja P. Khanna;Sangmee Bae

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: ACR RA Treatment Recommendations

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate

    Vibeke Strand;Stanley Cohen;Michael Schiff;Arthur Weaver

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.

    Jennifer M. Grossman;Rebecca Gordon;Veena K. Ranganath;Chad Deal

  • 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

    Dinesh Khanna;Puja P. Khanna;John D. FitzGerald;Manjit K. Singh

  • Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

    J. H. Korn;Maureen D Mayes;M. Matucci Cerinic;M. Rainisio

Frequent Co-Authors

Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Philip J. Clements
Philip J. Clements University of California, Los Angeles
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Christopher P. Denton
Christopher P. Denton University College London
Virginia D. Steen
Virginia D. Steen Georgetown University
Donald P. Tashkin
Donald P. Tashkin University of California, Los Angeles
Robin Christensen
Robin Christensen University of Southern Denmark
Paul Emery
Paul Emery University of Leeds
Oliver Distler
Oliver Distler University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in medicine, there are several flexible and affordable online degree options worth exploring. One popular route is medical billing and coding, which offers a fast entry point into healthcare with programs often spanning just several months. To better understand your options, check the average cost of medical billing and coding program and see how budgeting for these certifications compares to other paths.

Aspiring nurses and nurse practitioners can also benefit from online education. Prospective nurse practitioners can find the cheapest fnp programs online, offering a cost-effective way to advance in the field. If you're just starting out, it's helpful to know how much is online nursing school so you can plan your studies accordingly.

For those aiming high, pursuing a doctoral degree is possible through remote study as well. Accredited phd nursing programs online let you deepen your expertise and expand your career opportunities without sacrificing flexibility.

Best Scientists Citing Daniel E. Furst

Trending Scientists

Recently Published Articles